Drug misuse and dependency
Services
-
Drugs Test 1 (DT1) form
Form for the testing of specified class A drugs on persons ages 18 or over.
-
NDTMS: community combined review forms
Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
-
NDTMS: secure setting outcomes forms
Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.
Guidance and regulation
- Controlled drugs list
- COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
- Drug misuse and dependence: UK guidelines on clinical management
- Precursor chemical licensing
- Home Office approved testing kits: annex A
News and communications
- 4 expert ACMD board members reappointed
- Barriers to research beyond cannabinoids: call for evidence
- Response to the ACMD's advice on 2,4-Dinitrophenol (DNP)
- Advice on consumer CBD (cannabidiol) products
- Extra help for rough sleepers with drug and alcohol dependency
Research and statistics
- United Kingdom drug situation: Focal Point annual report
- Improving Lives: Helping Workless Families indicators 2021
- People who inject drugs: HIV and viral hepatitis monitoring
- Substance misuse treatment for young people: statistics 2019 to 2020
- Substance misuse treatment in secure settings: 2019 to 2020
Policy papers and consultations
- Independent review of drugs: call for evidence, part 2
- NDTMS annual reports and methodology: proposed changes
- ACMD ageing cohort of drug users report: government response
- Drug related harms in homeless populations: government response
- Drugs policy and medicinal cannabis report: government response
Transparency and freedom of information releases
- UK government Drug Recovery Champion annual report
- Standard Operating Procedure for using evidence in ACMD reports
- Commissioning impact on drug treatment
- Drug strategy 2016: development review
- Psychoactive Substances Bill: evaluation review